StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
February 1, 2016 8:33 AM
UBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Abbott (ABT), Alere (ALR) Deal has $177M Termination Fee
February 1, 2016 8:37 AM
Abbott (ABT) to Acquire Alere (ALR) for $56/Share
February 1, 2016 8:02 AM
Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
February 1, 2016 8:01 AM
William Blair Downgrades Abbott Labs (ABT) to Market Perform
January 29, 2016 7:28 AM
Pre-Open Stock Movers 01/28: (NEOS) (UA) (FB) Higher; (NOW) (OSIS) (EBAY) Lower (more...)
January 28, 2016 9:30 AM
Facebook 'likes' push Wall Street higher
January 28, 2016 7:38 AM
Abbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views
January 28, 2016 7:33 AM
Abbott Reports Fourth-Quarter 2015 Results
January 28, 2016 7:31 AM
